SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-053557
Filing Date
2021-11-02
Accepted
2021-11-02 16:11:05
Documents
14
Period of Report
2021-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rgnx-8k_20211102.htm   iXBRL 8-K 35603
2 EX-99.1 rgnx-ex991_24.htm EX-99.1 452304
3 GRAPHIC gk2p5sit1v5v000001.jpg GRAPHIC 15863
  Complete submission text file 0001564590-21-053557.txt   658874

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20211102.xsd EX-101.SCH 5673
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20211102_lab.xml EX-101.LAB 18571
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20211102_pre.xml EX-101.PRE 11026
7 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-8k_20211102_htm.xml XML 3416
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 211371422
SIC: 2836 Biological Products, (No Diagnostic Substances)